124 related articles for article (PubMed ID: 2539174)
1. High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.
Postmus PE; Haaxma-Reiche H; Sleijfer DT; Kirkpatrick A; McVie JG; Kleisbauer JP
Br J Cancer; 1989 Feb; 59(2):254-6. PubMed ID: 2539174
[TBL] [Abstract][Full Text] [Related]
2. High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results.
Postmus PE; Haaxma-Reiche H; Sleijfer DT; Kleisbauer JP; ten Velde G; Kirkpatrick A
Eur J Respir Dis Suppl; 1987; 149():65-71. PubMed ID: 3034652
[TBL] [Abstract][Full Text] [Related]
3. Podophyllotoxins for brain metastases of small cell lung cancer.
Haaxma-Reiche H; Berendsen HH; Postmus PE
J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
[TBL] [Abstract][Full Text] [Related]
4. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
5. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
6. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.
Malacarne P; Santini A; Maestri A
Oncology; 1996; 53(3):210-3. PubMed ID: 8643223
[TBL] [Abstract][Full Text] [Related]
7. Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases.
Lukas RV; Vigneswaran J; Salgia R
Tumori; 2013; 99(2):e73-6. PubMed ID: 23748834
[TBL] [Abstract][Full Text] [Related]
8. Remission of brain metastases from small-cell lung cancer after high-dose chemotherapy.
Postmus PE; Haaxma-Reiche H; Vencken LM; Meinesz AF; Sleijfer DT; Mulder NH
Ann Intern Med; 1984 Nov; 101(5):717. PubMed ID: 6091514
[No Abstract] [Full Text] [Related]
9. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
[TBL] [Abstract][Full Text] [Related]
10. Resolution of small cell lung cancer intracranial metastases with standard dose chemotherapy.
Kearns F; Grogan L; Harford P; Carney DN
Ir J Med Sci; 1989 Dec; 158(12):308-9. PubMed ID: 2560771
[TBL] [Abstract][Full Text] [Related]
11. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
[TBL] [Abstract][Full Text] [Related]
12. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of oral etoposide in elderly patients with small cell lung cancer.
Smit EF; Carney DN; Harford P; Sleijfer DT; Postmus PE
Thorax; 1989 Aug; 44(8):631-3. PubMed ID: 2477908
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
[TBL] [Abstract][Full Text] [Related]
17. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
18. Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.
Postmus PE; Holthuis JJ; Haaxma-Reiche H; Mulder NH; Vencken LM; van Oort WJ; Sleijfer DT; Sluiter HJ
J Clin Oncol; 1984 Mar; 2(3):215-20. PubMed ID: 6321690
[TBL] [Abstract][Full Text] [Related]
19. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
[TBL] [Abstract][Full Text] [Related]
20. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
